Introduction to immunotherapy for brain tumor patients: challenges and future perspectives
Skip to main content
eScholarship
Open Access Publications from the University of California

Introduction to immunotherapy for brain tumor patients: challenges and future perspectives

  • Author(s): Montoya, Megan L
  • Kasahara, Noriyuki
  • Okada, Hideho
  • et al.

Published Web Location

https://doi.org/10.1093/nop/npaa007
No data is associated with this publication.
Abstract

Abstract Abstract Malignant gliomas, including glioblastoma (GBM) as the most aggressive type of adult CNS tumors, are notoriously resistant to current standard of care treatments, including surgery, systemic chemotherapy, and radiation therapy (RT). This lack of effective treatment options highlights the urgent need for novel therapies, including immunotherapies. The overarching goal of immunotherapy is to stimulate and activate the patient’s immune system in a targeted manner to kill tumor cells. The success of immunotherapeutic interventions in other cancer types has led to interest in and evaluation of various experimental immunotherapies in patients with malignant gliomas. However, these primary malignant brain tumors present a challenge because they exist in a vital and sensitive organ with a unique immune environment. The challenges and current status of experimental immunotherapeutic approaches, including vaccines, immune-checkpoint blockade, chimeric antigen receptor T-cell therapy, and oncolytic viruses will be discussed, as well as the potential for combinatorial therapies.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content

This item is under embargo until September 18, 2020.